In accordance with molecular imaging TNM (miTNM) definition [19,20], the identified PCa lesions were categorized as follows: prostate bed (miTr) in 8.1% of cases (36/443); pelvic nodes (miN1) in 21.2% (94/443); extra-pelvic nodes (miM1a) in 7.7% (34/443); bone metastasis (miM1b) in 9.9% (44/443); and visceral non-nodal metastasis (miM1c) in 2.5% (11/443). The gene discussed is CD59; the disease is posterior cortical atrophy.